Chempartner Pharmatech Co Ltd Class A 300149
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 5.13
- Day Range
- CNY 5.10–5.22
- 52-Week Range
- CNY 3.68–9.74
- Bid/Ask
- CNY 5.17 / CNY 5.18
- Market Cap
- CNY 2.59 Bil
- Volume/Avg
- 5.3 Mil / 13.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.32
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,916
- Website
- https://www.cppt.com.cn
Comparables
Valuation
|
Metric
|
300149
|
688062
|
688197
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 1.78 | 5.58 | 7.63 |
Price/Sales | 2.32 | 70.17 | 1,410.94 |
Price/Cash Flow | 13.02 | — | — |
Price/Earnings
300149
688062
688197
Financial Strength
|
Metric
|
300149
|
688062
|
688197
|
|---|---|---|---|
Quick Ratio | 1.54 | 1.85 | 5.50 |
Current Ratio | 1.76 | 2.11 | 8.50 |
Interest Coverage | −30.81 | −45.93 | −2,090.39 |
Quick Ratio
300149
688062
688197
Profitability
|
Metric
|
300149
|
688062
|
688197
|
|---|---|---|---|
Return on Assets (Normalized) | −2.10% | −13.56% | −18.00% |
Return on Equity (Normalized) | −3.21% | −21.55% | −19.55% |
Return on Invested Capital (Normalized) | −2.01% | −15.44% | −21.58% |
Return on Assets
300149
688062
688197
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Lbklwnfp | Mfq | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Wdswvdv | Ywzfsc | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mggsydqy | Jmwxtn | $108.2 Bil | |
MRNA
| Moderna Inc | Lzjbyrxlx | Lll | $50.9 Bil | |
ARGX
| argenx SE ADR | Ppfwrgdq | Jfy | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Shngzthz | Vmfz | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zmhjlwdrq | Vjcfml | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Mwslhcxk | Ckkrtl | $14.6 Bil | |
INCY
| Incyte Corp | Vkbzhbq | Jlbrqv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Twkgsflbf | Cqhlzmx | $12.3 Bil |